Cases 51 - 60 of 5,523
Burlington Drug Company, Inc. et al v. Merck & Company, Inc. et al
as 2:2022cv00269
Plaintiff:
Burlington Drug Company, Inc., Dakota Drug, Inc., J M Smith Corporation doing business as Smith Drug Company and others
Defendant:
Merck & Company, Inc., Merck Sharp & Dohme Corporation, Schering-Plough Corporation and others
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
Giant Eagle, Inc. v. Merck & Co, Inc. et al
as 2:2022cv00268
Plaintiff:
Giant Eagle, Inc.
Defendant:
Merck & Co, Inc., Merck Sharp & Dohme Corp., Schering-Plough Corp. and others
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
Ortmann v. Aurinia Pharmaceuticals Inc. et al
as 8:2022cv01335
Plaintiff:
Michael J. Ortmann
Defendant:
Aurinia Pharmaceuticals Inc., Peter Greenleaf and Joseph Miller
Petitioner:
Rasik Cauchon-Desai, ACDC Investments Limited, Roney Balson and others
AstraZeneca AB et al v. Mylan Pharmaceuticals Inc. et al
as 1:2022cv00035
Plaintiff:
AstraZeneca AB and Astrazeneca Pharmaceuticals LP
Defendant:
Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Vanda Pharmaceuticals, Inc. v. Centers for Medicare & Medicaid Services et al
as 1:2022cv00977
Plaintiff:
Vanda Pharmaceuticals, Inc.
Defendant:
Centers for Medicare & Medicaid Services and Chiquita Brooks-LaSure
Cause Of Action: 05 U.S.C. § 551 Administrative Procedures Act
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
as 1:2022cv00032
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc.
as 1:2022cv00023
Counter Defendant:
Novo Nordisk, Inc. and Novo Nordisk, A/S
Defendant:
Mylan Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BAUSCH HEALTH IRELAND LIMITED et al v. MYLAN LABORATORIES LTD. et al
as 1:2022cv00020
Plaintiff:
Bausch Health Ireland Limited and Salix Pharmaceuticals, Inc
Defendant:
Mylan Laboratories Ltd., Agila Specialties Inc., Mylan API US LLC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
FISHER v. FENNEC PHARMACEUTICALS INC. et al
as 1:2022cv00115
Plaintiff:
JEFFREY D. FISHER
Defendant:
FENNEC PHARMACEUTICALS INC., ROSTISLAV RAYKOV and ROBERT ANDRADE
A.D.A. v. Johnson & Johnson et al
as 5:2022cv00015
Plaintiff:
A.D.A.
Defendant:
Johnson & Johnson, Janssen Pharmaceuticals, Inc., Noramco and others
Cause Of Action: 28 U.S.C. § 1332
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
